Senior Territory Account Manager

Iowa, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Genomics, Life Sciences, Healthcare TechnologyIndustries

Requirements

Candidates must have a minimum of 5 years of proven life science capital sales experience, with knowledge of clinical and research applied genetics and genomics. Demonstrable experience working with key clinical and research accounts in Iowa and Illinois (excluding Chicago) is required. Success in consultative selling, lead generation, business development, and working collaboratively in a fast-paced environment is essential. Understanding of next-generation sequencing (NGS) and genotyping is foundational.

Responsibilities

The Senior Territory Account Manager is responsible for achieving territory sales objectives and growth targets by developing and implementing sales plans. This includes accurate sales forecasting, pipeline management, and proactive CRM utilization. Responsibilities also involve delivering technical seminars, consulting with customers on Illumina products, and staying informed about market trends. The role requires effective cross-functional collaboration, managing complex sales processes, prospecting new business, expanding existing accounts, and maintaining strong customer relationships.

Skills

Territory Account Management

Sales Planning

Sales Forecasting

Market Analysis

Competitor Analysis

Genomics

Applied Genetics

Capital Sales

Lead Generation

Prospecting

Business Development

Consultative Selling

Strategic Selling

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free